HCPCS Q9969 is officially defined as "Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose." HCPCS Q9969 is referenced in 2 tracked payer policy changes from Independence Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS Q9969 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.